Funding for this research was provided by:
United States Agency for International Development (AID-OAA-G-14-00008)
Bundesministerium für Bildung und Forschung (7694)
Received: 27 November 2019
Accepted: 16 March 2020
First Online: 30 March 2020
Ethics approval and consent to participate
: The core protocol was reviewed and approved by the Western IRB (20160438, 9 Sep 2017). In addition, each country obtained local approval from the local/national review bodies as follows: India: Drugs Controller of India (CT/ND/49/2018, 10 Oct 2018); Mali: College of Pharmacy, Medicine and Odonto-Stomatology (ERC-2016/150/CE/EMPOS, 15 Dec 2016); Sri Lanka: University of Colombo (ERC-EC-17-002, 12 Feb 2018); Cameroon: University of Buea Faculty of Health Sciences (ERC-745-12, 22 Jan 2018); Ghana: Ghana Health Services (ERC-007/07/17, 19 Dec 2017); Tanzania: National Institute of Medical Research (NIMR/HQ/R.8a/Vol.IX/2693).
: Not applicable.
: JPS is an employee of the United States Agency for International Development. All other authors declare that they have no competing interests.